InvestorsHub Logo

north40000

04/07/21 12:02 PM

#333641 RE: Gusman #333637

1) Those of us with Vascepa prescriptions, now on-label after 12/19, will continue to receive Vascepa label capsules.

2) In above situation, we might receive Vazkepa prescriptions. With both marks registered in U.S., it seems easier to retain Vascepa label for broader label indications.

I see where Brady is launching an nft company.

Toddrobertking

04/07/21 12:03 PM

#333642 RE: Gusman #333637

interesting idea

Can they legally do that?

rosemountbomber

04/07/21 12:22 PM

#333649 RE: Gusman #333637

Why couldn’t they? The exact same active ingredient. But it would be nice if it would work.

ralphey

04/07/21 12:26 PM

#333650 RE: Gusman #333637

Yes GUsman

ANother strategy on using a reset button but since Vazkepa is still EPA whats to prevent the substitution from occurring as they now are ? Yes its not indicated yes its patent infringement but insurance companies will still substitute - we will still need legal actions to prevent ...

Similar to my Vastor idea but a bit easier to make the substitution